Prosecution Insights
Last updated: April 19, 2026

Examiner: LAFAVE, ELIZABETH ROSE

Tech Center 1600 • Art Units: 1684

This examiner grants 48% of resolved cases

Performance Statistics

48.5%
Allow Rate
-11.5% vs TC avg
80
Total Applications
+59.6%
Interview Lift
1493
Avg Prosecution Days
Based on 33 resolved cases, 2023–2026

Rejection Statute Breakdown

11.5%
§101 Eligibility
29.9%
§102 Novelty
23.7%
§103 Obviousness
32.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17421573 DNA METHYLATION MEASUREMENT FOR MAMMALS BASED ON CONSERVED LOCI Final Rejection ILLUMINA, INC.
17756336 GENETICALLY-DIRECTED SPARSE AND COMPLETE LABELING OF BRAIN CELLS Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17582820 CRISPR/CAS TRANSCRIPTIONAL MODULATION Non-Final OA The Regents of the University of California
18052179 SYSTEMS AND METHODS FOR SURFACE STRUCTURING Final Rejection Nautilus Subsidiary, Inc.
17604881 BIOPOLYMER ANALYSIS DEVICE, BIOPOLYMER ANALYSIS EQUIPMENT, AND BIOPOLYMER ANALYSIS METHOD Final Rejection HITACHI HIGH-TECH CORPORATION
17435610 PROTEIN RESIDUE MAPPING USING A COMBINATION OF DEEP MUTATIONAL SCANNING AND PHAGE DISPLAY HIGH THROUGHPUT SEQUENCING Non-Final OA Fred Hutchinson Cancer Center
17776404 LIBRARY OF BARCODED EXTRACELLULAR VESICLES Final Rejection The University of Tokyo
17890632 Surface-Based Tagmentation Final Rejection Illumina Cambridge Limited
17633467 HIGH-THROUGHPUT SCREENING PLATFORM FOR ENGINEERING NEXT-GENERATION GENE THERAPY VECTORS Final Rejection Duke University
18009377 A Method for Assessing Transduction Efficiency and/or Specificity of Vectors at Single Cell Level Non-Final OA AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
17610414 METHODS AND COMPOSITIONS FOR ENHANCED GENOME COVERAGE AND PRESERVATION OF SPATIAL PROXIMAL CONTIGUITY Final Rejection ARIMA GENOMICS, INC.
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS Final Rejection Keygene N.V.
17923506 COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES Non-Final OA Pacific Biosciences of California, Inc.
18041902 EUKARYOTIC DNA REPLICATION ORIGINS, AND VECTOR CONTAINING THE SAME Non-Final OA UNIVERSITÉ DE MONTPELLIER
17494155 ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS Final Rejection Meso Scale Technologies, LLC.
17602392 DUPLEX-SPECIFIC NUCLEASE DEPLETION FOR PURIFICATION OF NUCLEIC ACID SAMPLES Non-Final OA ZYMO RESEARCH CORPORATION
17781650 SPATIAL BARCODING Final Rejection CANCER RESEARCH TECHNOLOGY LIMITED
17323834 DETECTION AND PREDICTION OF INFECTIOUS DISEASE Final Rejection KARIUS, INC.
18554942 COMPOSITIONS AND METHODS FOR IN VIVO SCREENING OF THERAPEUTICS Non-Final OA Gordian Biotechnology, Inc.
17284853 Single cell full length RNA sequencing Non-Final OA Koninklijke Nederlandse Akademie van Wetenschappen
17721680 BARCODE-BASED NUCLEIC ACID SEQUENCE ASSEMBLY Final Rejection Twist Bioscience Corporation
17430605 METHOD OF DETERMINING THE ORIGIN OF NUCLEIC ACIDS IN A MIXED SAMPLE Non-Final OA NIPD GENETICS PUBLIC COMPANY LIMITED
17430741 QUANTITATIVE MAPPING OF CHROMATIN ASSOCIATED PROTEINS Final Rejection EPICYPHER, INC.
17429729 CHROMATIN MAPPING ASSAYS AND KITS USING LONG-READ SEQUENCING Non-Final OA EPICYPHER, INC.
17786464 METHOD AND KIT FOR WHOLE GENOME AMPLIFICATION AND ANALYSIS OF TARGET MOLECULES IN A BIOLOGICAL SAMPLE Non-Final OA Menarini Silicon Biosystems S.P.A.
17751023 METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION Non-Final OA Singleron Biotechnologies Inc.
17436044 INTRAGENIC ASSESSMENT AND METHODS THEREFOR Final Rejection THE SYDNEY CHILDREN'S HOSPITALS NETWORK (RANDWICK AND WESTMEAD) (INCORPORATING THE ROYAL ALEXANDRA
17285846 METHODS AND REAGENTS FOR EFFICIENT GENOTYPING OF LARGE NUMBERS OF SAMPLES VIA POOLING Final Rejection TwinStrand Biosciences, Inc.
17282728 NORMALIZATION CONTROLS FOR MANAGING LOW SAMPLE INPUTS IN NEXT GENERATION SEQUENCING Non-Final OA ARC BIO, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month